Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £189.7m
Position in Universe th / 6852

Thailand gives emergency use authorisation for Sinovac's COVID-19 vaccine - official

Mon 22nd February, 2021 12:33pm
BANGKOK, Feb 22 (Reuters) - Thailand's Food and Drug
Administration (FDA) has given emergency use authorisation for
Sinovac Biotech's  SVA.O  coronavirus vaccine, a senior official
told Reuters on Monday. 
    "The FDA has approved or registered Sinovac's COVID-19
vaccine for conditional emergency use, effective Feb. 22," FDA
deputy secretary-general Surachok Tangwiwat said, adding it was
valid for one year 
    

 (Reporting by Panarat Thepgumpanat; Writing by Patpicha
Tanakasempipat; Editing by Martin Petty)
 ((patpicha.tanakasempipat@tr.com; +66818317884; @patpichatan;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.